Bank of America
INDV icon

Bank of America’s Indivior Pharmaceuticals INDV Stock Holding History

Bank of America’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26M Sell
632,967
-34,165
-5% -$1.24M ﹤0.01% 2252
2026
Q1 		$20.3M Sell
667,132
-137,103
-17% -$4.53M ﹤0.01% 2378
2025
Q4 		$28.9M Buy
804,235
+475,721
+145% +$14.5M ﹤0.01% 1986
2025
Q3 		$7.92M Sell
328,514
-158,402
-33% -$3.31M ﹤0.01% 3541
2025
Q2 		$7.18M Buy
486,916
+96,192
+25% +$1.12M ﹤0.01% 3532
2025
Q1 		$3.72M Sell
390,724
-857,541
-69% -$9.02M ﹤0.01% 4115
2024
Q4 		$15.5M Sell
1,248,265
-401,697
-24% -$4.13M ﹤0.01% 2531
2024
Q3 		$16.1M Sell
1,649,962
-2,411,460
-59% -$28.2M ﹤0.01% 2608
2024
Q2 		$65.5M Buy
4,061,422
+1,579,397
+64% +$28.5M 0.01% 1278
2024
Q1 		$53.2M Sell
2,482,025
-152,644
-6% -$2.87M ﹤0.01% 1444
2023
Q4 		$40.2M Sell
2,634,669
-67,186
-2% -$1.19M ﹤0.01% 1523
2023
Q3 		$62.3M Buy
2,701,855
+314,940
+13% +$7.18M 0.01% 1156
2023
Q2 		$56.8M Buy
+2,386,915
New +$54.7M 0.01% 1215

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America's INDV Position: Q2 2026 in Review

Bank of America reduced its Indivior Pharmaceuticals (INDV) stake by 5.1% in Q2 2026, selling an estimated $1.24M and leaving 632,967 shares worth $26M. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Bank of America first reported a position in INDV in Q2 2023 and has held it in 13 quarters since. The position peaked at $65.5M in Q2 2024. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Bank of America held 632,967 shares of Indivior Pharmaceuticals worth $26M as of Q2 2026.
  • Bank of America sold 34,165 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.24M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2252 holding.
  • Bank of America first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Bank of America's Indivior Pharmaceuticals position peaked at $65.5M in Q2 2024.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.